OXANDRIN *
Manufacturer Details
BIO-TECHNOLOGY (GENERAL) INC
Compositions:
Oxandrolone 2.5mg tabs,
|
Strength
|
Rate
|
Packing Style
|
|
2.5mg
|
0.00
|
Tab
|
List of Related Indications:
- Adjuvant therap- weight gain
List Of Drugs:
- Oxandrolone - @ Anabolic steroids- (Aug 2006)
Indication Type Description:
Drug Interaction:
Analbolic steroids include- Oxymetholone, Stanazolol, Oxandrolone, Nandrolone phenpropionate, Nandrolone deconate,
Refer - Nandrolone
Indication:
LIST OF DRUGS DURING 2006
Sr.No- 91
Name of the Drug- Oxandralone Tablet (2.5/10mg) Pharmacological Classification- To promote weight gain
Date of Approval- 04-08-2006
Approved by U.S.FDA on 30-12-2006 (Ref- FDA approved List)
New Drugs Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
Oxandrolone 04-08-2006
2.5mg/10mg Tablet
To promote weight gain
Adjuvant therapy to promote weight gain after weight loss from surgery
Analbolic steroids include- Oxymetholone, Stanazolol, Oxandrolone, Nandrolone phenpropionate, Nandrolone deconate,
Refer - Nandrolone
Dosages/ Overdosage Etc:
To promote weight gain
Indication:
Adjuvant therapy to promote weight gain after weight loss from surgery
Dosage:
Individualise dosage.
Use intermittent therapy Adults- 2.5mg 2 or 4 times daily Children- total daily dosage is less than 0.1mg/kg .
Patient Information:
Analbolic steroids include-
Oxymetholone, Stanazolol, Oxandrolone, Nandrolone phenpropionate, Nandrolone deconate,
Refer - Nandrolone
Pregnancy and lactation:
Analbolic steroids include-
Oxymetholone, Stanazolol, Oxandrolone, Nandrolone phenpropionate, Nandrolone deconate,
Refer - Nandrolone
